The Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for
Pruritus and features dormant and discontinued projects. The guide covers therapeutics under Development
by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I,
IND/CTA Filed and Preclinical stages are 4, 12, 6, 1 and 8 respectively. Similarly, the Universities portfolio in
Preclinical and Discovery stages comprises 3 and 1 molecules, respectively.
Pruritus (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and
their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain
competitive advantage. The guide is built using data and information sourced from proprietary databases,
company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third-party sources. Additionally,
various dynamic tracking processes ensure that the most recent developments are captured on a real time
basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and
relevance of data.
Request A Sample copy of This Report @
https://www.hexareports.com/report/pruritus-pipeline-review-h2-2017/request-sample
Scope
•
•
•
•
•
•
•
•
The pipeline guide provides a snapshot of the global therapeutic landscape of Pruritus (Dermatology).
The pipeline guide reviews pipeline therapeutics for Pruritus (Dermatology) by companies and
universities/research institutes based on information derived from company and industry-specific
sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-
registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product
description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental
activities.
The pipeline guide reviews key companies involved in Pruritus (Dermatology) therapeutics and enlists
all their major and minor projects.
The pipeline guide evaluates Pruritus (Dermatology) therapeutics based on mechanism of action
(MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Pruritus (Dermatology)
Reasons To Buy
•
Procure strategically important competitor information, analysis, and insights to formulate effective
R&D strategies.
Follow Us: